Opinion

» agriculture and opinion

Most Recent

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

0 Comments

image: Opinion: Pay-to-Play Publishing

Opinion: Pay-to-Play Publishing

By | September 3, 2015

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

2 Comments

image: Opinion: On Global GMO Regulation

Opinion: On Global GMO Regulation

By | February 25, 2015

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

1 Comment

image: Opinion: The Planet Needs More Plant Scientists

Opinion: The Planet Needs More Plant Scientists

By | October 1, 2014

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

17 Comments

image: Opinion: Bumblebees in Trouble

Opinion: Bumblebees in Trouble

By | June 30, 2014

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

0 Comments

image: Opinion: Restoring Tomato Flavor

Opinion: Restoring Tomato Flavor

By | August 28, 2013

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

4 Comments

image: Opinion: Evolving CO2-Hungry Crops

Opinion: Evolving CO2-Hungry Crops

By and | December 4, 2012

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

1 Comment

image: Opinion: Super Storm Sandy

Opinion: Super Storm Sandy

By | October 31, 2012

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

12 Comments

image: Opinion: Fishy Deaths

Opinion: Fishy Deaths

By | October 29, 2012

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

1 Comment

image: Opinion: Think Like Turing

Opinion: Think Like Turing

By | October 22, 2012

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

2 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech